Cytokinetics, Incorporated is a late-stage, specialty cardiovascular biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which cardiac muscle performance is compromised. Co. specializes in muscle biology and the mechanics of muscle performance. It is developing small molecule drug candidates specifically engineered to impact myocardial muscle function and contractility. Its cardiac muscle contractility program is focused on the cardiac sarcomere. We show 49 historical shares outstanding datapoints in our CYTK shares outstanding history coverage, used to compute CYTK market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CYTK market cap history over the course of time is important for investors
interested in comparing CYTK's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CYTK versus a peer is one thing; comparing
CYTK market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CYTK can fluctuate over the course of history.
With this page we aim to empower investors researching CYTK by allowing them to research the CYTK market cap history. |
Free CYTK Email Alerts:
Video: The Importance of Market Cap
